Company Filing History:
Years Active: 2025
Title: Ondrej Kostov: Innovator in Pharmaceutical Chemistry
Introduction
Ondrej Kostov is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for treating diseases through the modulation of specific proteins.
Latest Patents
Ondrej Kostov holds a patent for 2'3′-cyclic dinucleotides and prodrugs thereof. This patent relates to 2'3′ cyclic phosphonate dinucleotides of Formula (I), including their pharmaceutically acceptable salts, pharmaceutical compositions, and combinations with other substances. The compounds disclosed in this patent are aimed at treating or preventing diseases modifiable by STING protein modulation, such as cancer, viral infections, and various allergic and inflammatory diseases. He has 1 patent to his name.
Career Highlights
Kostov is affiliated with the Institute of Organic Chemistry and Biochemistry, ASCR, v.v.i., where he conducts his research and development activities. His work has been instrumental in advancing the understanding of cyclic dinucleotides and their therapeutic potential.
Collaborations
He collaborates with esteemed colleagues, including Gabriel Birkus and Ondrej Pav, to further enhance the impact of his research in the scientific community.
Conclusion
Ondrej Kostov's innovative work in pharmaceutical chemistry exemplifies the importance of research in developing new treatments for complex diseases. His contributions continue to pave the way for advancements in medical science.